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Abstract
Summary We assessed the ability of a fracture liaison service
(FLS) to directly reduce re-fracture risk. Having a FLS is
associated with a ∼40 % reduction in the 3-year risk of major
bone and ∼30 % of any bone re-fracture. The number needed
to treat to prevent a re-fracture is 20.
Introduction FLS have been promoted as the most effective
interventions for secondary fracture prevention, and while
there is evidence of increased rate of investigation and treat-
ment at institutions with a FLS, only a few studies have con-
sidered fracture outcomes directly. We therefore sought to
evaluate the ability of our FLS to reduce re-fracture risk.
Methods Historical cohort study of all patients ≥50 years pre-
senting over a 6-month period with a minimal trauma fracture
(MTF) to the emergency departments of a tertiary hospital
with a FLS, and one without a FLS. Baseline characteristics,
mortality and MTFs over a 3-year follow-up were recorded.
Results Five hundred fifteen patients at the FLS hospital and
416 patients at the non-FLS hospital were studied. Over
3 years, 63/515 (12 %) patients at the FLS hospital and 70/
416 (17 %) at the non-FLS hospital had a MTF. All patients
were analysed in an intention-to-treat analysis regardless of
whether they were seen in the FLS follow-up clinic. Statistical
analysis using Cox proportional hazardmodels in the presence
of a competing risk of death from any cause was used. After
adjustment for baseline characteristics, there was a ∼30 %
reduction in rate of any re-fracture at the FLS hospital (hazard
ratio (HR) 0.67, confidence interval (CI) 0.47-0.95, p value
0.025) and a ∼40% reduction inmajor re-fractures (hip, spine,
femur, pelvis or humerus) (HR 0.59, CI 0.39-0.90, p value
0.013).
Conclusions We found a ∼30 % reduction in any re-fractures
and a ∼40 % reduction in major re-fractures at the FLS hos-
pital compared with a similar non-FLS hospital. The number
of patients needed to treat to prevent one new fracture over
3 years is 20.
Keywords Bone/prevention and control . Fracture liaison
service . Fractures . Osteoporosis/epidemiology .
Osteoporotic fractures/prevention and control . Secondary
prevention
Introduction
Minimal trauma fracture (MTF) is the cardinal risk of osteo-
porosis [1–5]. In particular, patients who suffer a first fracture
are at greater risk of a second fracture, within 1 or 2 years of
the first, if their osteoporosis remains untreated [2]. In the case
of hip fractures, almost half have a prior history of a MTF [6].
The impact on the individual is devastating. For example, hip
fractures have a 24 % 12-month mortality, 85 % of survivors
need assistance to walk and 20 % require nursing home care
[7–9]. While the age-specific incidence of hip fractures may
be declining, the actual numbers are continuing to increase
due to the numbers of older persons in the population [10,
11]. The steeply rising incidence of MTFs is creating an in-
creasing public health and economic burden. The problem is
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worldwide with projected costs rising to 37 billion
Euros in Europe by 2025 and 12.5 billion US dollars
in China by 2020, with similar projections for the
Americas and the Pacific including Australia [12]. This
has led to position papers being issued by the Interna-
tional Osteoporosis Foundation (IOF) and the American
Society for Bone and Mineral Research calling for the
creation and implementation of fracture liaison services
(FLS) as the most efficient way of addressing the prob-
lem [12–14]. These services are designed to identify
patients who suffer a first fracture, assess their bone
metabolic status and institute medical therapy as indicat-
ed, in order to prevent a second fracture. There has
been a broad acceptance of these proposals, and as a
measure of their implementation, the IOF website
(www.capturethefracture.org) lists 109 sites worldwide
with an active FLS.
The value of FLS and similar services has been supported
by a number of published analyses of their effectiveness.
These studies have shown increased patient assessment and
commencement of treatment with projected clinical benefits
and cost savings [15–18]. However, there remains a paucity of
studies looking at the effectiveness of FLS in achieving their
primary task of reducing re-fracture rates [19–22]. At the same
time, recurring criticism of the strategy of focusing on the
treatment of osteoporosis as the best way to reduce fragility
fractures highlights the importance of evaluating intervention
outcomes in terms of their actual impact on the fracture rate
[23–25].
Earliest studies either relied on historical data for
controls [22] or compared rates of subsequent fracture
in patients who did or did not attend a designated clinic
within the FLS [20]. The control group was a sample of
eligible patients who elected not to attend the clinic,
which introduces a risk of sampling bias. Likewise, a
later study that compared patients attending and not at-
tending a review clinic used one in four samples, in
chronologic order, of patients choosing not to attend
the clinic [21]. A third study compared re-fracture rates
between all patients presenting either to a hospital with
an FLS or one with no such service. Capturing all pa-
tients generated large sample sizes and small confidence
intervals of proportions. A significant difference in fa-
vour of the FLS was only demonstrable however as a
time dependant outcome when cumulative fracture inci-
dence over time was calculated [19].
The present study was undertaken to evaluate the
effect of a FLS on re-fracture risk and provide grounds
for outcome-based decision-making about the value of
having such a service. In light of the literature, the
study was designed to recruit a large sample of patients
attending a hospital with or without a FLS and analyse
results on an intention-to-treat basis.
Methods
Programme description
JohnHunter Hospital is a tertiary public hospital and the major
trauma referral centre for the Hunter New England Local
Health District (located in Newcastle, New SouthWales, Aus-
tralia). The Hunter New England Local Health District covers
a region of 131,785 km2, spanning 25 local government areas
with an estimated resident population of 873,741 people;
19.4 % of residents are born overseas and 4 % are Aboriginal
and Torres Strait Islander people. The John Hunter Hospital
FLS has been in operation since 2007. It is a service which
identifies, investigates and treats patients with MTFs. Most
patients who are identified as having a MTF are automatically
given an appointment at the FLS clinic. For logistical reasons,
patients discharged to an Aged Care Facility (nursing home or
hostel) and those who live out of the area are not given an
automatic appointment. These patients are sent a letter and
pamphlet informing them that they have had a MTF and
should be investigated and treated, with a recommendation
to see their general practitioners. Their general practitioner is
also sent a letter including information on a local health
website that guides osteoporosis investigation and manage-
ment. Other patients who are not seen in clinic may be patients
who have died, are palliative, have been seen as an inpatient or
those who choose not to come to clinic after being given an
appointment. All patients seen in the FLS clinic are investi-
gated for osteoporosis and secondary causes of osteoporosis,
given lifestyle and dietary education and treated for osteopo-
rosis if appropriate.
The comparator hospital was chosen because it is a tertiary
public hospital in NSW of similar size to the John Hunter
Hospital, is the major trauma referral centre of its area and
does not have a FLS. The non-FLS hospital is an 877-bed
hospital (2015), providing state-wide services in areas such
as trauma. The local health district spans seven local govern-
ment areas and covers a region with a resident population of
888,000 people. The area is home to people from diverse
cultures with 40 % born overseas, with the most common
countries of birth outside Australia being Fiji (3.4 %), Iraq
(3.3 %) and Vietnam (2.8 %). The hospital has no specific
osteoporosis or secondary fracture prevention service but does
have endocrinology, rheumatology and aged care services.
The study was approved by the Hunter New England Hu-
man Research Ethics committee.
Data collection
At both the FLS hospital and the non-FLS hospital, lists were
created of patients who were aged ≥50 years, and had had a
diagnostic code for fracture from their emergency department
(ED) presentation described by S02.0 (Fracture of Skull) to
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S92.9 (Fracture of Foot) but excluding any where the descrip-
tion includes Bsprains and strains^, Bdislocation^, Binjury ,^
Bwound^, Btrauma^ or Bburn^ between July and December
2010. Patients without a MTF, or those that were seen at the
FLS clinic before July 2010, were excluded. A MTF was
defined as a fracture from a fall from a standing height or less
trauma. This was determined by looking at ambulance, triage,
ED clinical notes, discharge summaries or inpatient progress
notes that were electronically stored on the respective hospi-
tal’s computer systems. If patients were diagnosed as having a
fracture but their imaging reported no fracture, these patients
were also excluded. Given the size and historical nature of the
study, only information that could be obtained through the
hospital computer systems could be collected. Baseline char-
acteristics that were considered to be potential confounders
were collected. These included age, gender and postcode as
a surrogate marker of socioeconomic status, aboriginal and
Torres Strait Islander status, type of initial baseline fracture,
whether patients were on treatment at discharge from hospital,
and discharge to an Aged Care Facility (either hostel or nurs-
ing home). At the FLS hospital, it was recorded whether the
patient received a clinic appointment and whether they
attended. The date and type of re-fractures were recorded if
they were MTFs and were identified on each hospital comput-
er system by looking through subsequent hospital encounters
and radiology reports. Re-fractures could be identified only if
patients had re-presented to the same hospital or a hospital that
was part of the same computer network. Death was recorded
from the hospital computer system and confirmed through the
NSW State Death and Birth Registries by matching their
names and date of births.
Statistical analysis
We used Cox proportional hazard models to model the event-
specific risk (cumulative incidence function) of bone re-
fracture during follow-up in the presence of a competing risk
using the method of Fine and Gray [26]. The competing risk
was defined as death from any cause. This method is a mod-
ification of the Cox proportional hazard model that accounts
for participants who experience a competing event (death) that
prevents observation of the event of interest (bone re-fracture).
The modification involves retaining participants in the risk set
with a diminishing weight when they die, rather than simply
censoring them at the time of death. This is the most widely
accepted method for unbiased estimation of incidence rates
and exposure effects in the presence of competing risks [27].
Covariate effects (hazard ratios) are modelled in relation to the
event-specific sub-distribution and are expressed as sub-
distribution hazard ratios. We employed intention-to-treat
principles to compare the re-fracture rates including all pa-
tients with minimal trauma fracture regardless of whether they
were seen in the FLS clinic or not.
The covariates included in multivariate models included
the following:
1. Patient age at admission for original fracture (as a cate-
gorical variable: <65 or ≥65 years) The cutoff of 65 years
was chosen a priori as a standard threshold for defining a
senior citizen/retirement age. Age was not used as a con-
tinuous value to avoid the assumption of a linear effect.
2. Patient gender
3. Patient socioeconomic status, approximated by the Aus-
tralian Bureau of Statistics (ABS) Socio-Economic Index
For Area (SEIFA) Index of Relative Socio-Economic Ad-
vantage and Disadvantage (IRSAD) [28] for the patient’s
residential postcode.
4. Skeletal bone sustaining the original fracture. This was
categorised as major (hip, spine, femur, pelvis or humer-
us) or minor (all other bones including radius, ulna, hand,
tibia, fibula, foot, ribs, clavicle, facial, patella, scapula,
skull and sternum).
Patients’ treatment status and Aged Care Facility status was
not included in the model as these data were collected on the
patient at discharge and therefore may have been influenced
by the intervention. A record of medications on admission to
ED was not consistently available in ED admission notes,
especially if the patient was discharged from ED back to home
and not admitted to hospital, and when it was present, it was
incompletely recorded. We judged that there was too much
missing data for this field to be included in this analysis. Al-
though Aged Care Facility status was not included in the anal-
ysis, postcode of residence was captured and used to link to
the SEIFA code which was used as a measure of socioeco-
nomic status and adjusted for. The multivariate modelling ap-
proach involved including all variables (exposure and covar-
iates) in the initial model. Covariates were then removed if
their association with the outcome was non-significant (at α=
0.1), and their removal produced no substantive change in
coefficients for the remaining variables. A substantive change
was defined as greater than approximately 10 %. The justifi-
cation for model reduction was to maximise power, since the
number of events was modest for some analyses. For present
purposes, only the final reduced model is reported.
The proportional hazard assumption was checked by in-
cluding each predictor variable as a time-varying covariate
and ensuring no significant time variation was observed. If
significant time variation was observed for a given predictor
variable, the interaction between that variable and analysis
time was included in the model as an additional term.
For the final model, results are presented as sub-
distribution hazard ratios for risk factors at the patient level.
Results were considered significant if the p value was <0.05.
Based on final multivariate models, cumulative incidence
functions (also known as cause-specific sub-distributions)
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were estimated and plotted for the two hospitals (FLS and
non-FLS hospital), adjusted for all other covariates retained
in the model.
All statistical analyses were programmed using Stata v13.0
(Stata Corp Ltd, College Station, TX).
Results
The total numbers of patients aged ≥50 years, with a fracture
ED code, presenting July–December 2010 were 807 at the
FLS hospital and 1059 at the non-FLS hospital. Duplicates,
Table 1 Patient characteristics at
the two recruiting hospitals Characteristic Class/statistic Non-FLS hospital FLS hospital
Total patients 416 (44.7 %) 515 (55.3 %)
Age Mean (SD) 75.0 (12.1) 76.6 (12.4)
Median (min, max) 77 (50, 99) 79 (50, 100)
Age group <65 99 (23.8 %) 102 (19.8 %)
≥65 317 (76.2 %) 413 (80.2 %)
Gender Male 110 (26.4 %) 127 (24.7 %)
Female 306 (73.6 %) 388 (75.3 %)
Fracture type (3 categories)a Hip 95 (22.9 %) 199 (38.6 %)
Major (excluding hip)b 126 (30.4 %) 114 (22.1 %)
Minorc 194 (46.8 %) 202 (39.2 %)
Fracture type (2 categories)a Majorb 221 (53.3 %) 313 (60.8 %)
Minorc 194 (46.8 %) 202 (39.2 %)
Re-fracture during follow-up Yes 70 (16.8 %) 63 (12.2 %)
No 346 (83.2 %) 452 (87.8 %)
Re-fracture type None 346 (83.2 %) 452 (87.8 %)
Majorb 50 (12.0 %) 42 (8.2 %)
Minorc 20 (4.8 %) 21 (4.1 %)
Number of re-fractures 0 346 (83.2 %) 452 (87.8 %)
1 53 (12.7 %) 51 (9.9 %)
2 16 (3.9 %) 10 (1.9 %)
3 1 (0.24 %) 2 (0.39 %)
Death during follow-up Yes 108 (26.0 %) 167 (32.4 %)
No 308 (74.0 %) 348 (67.6 %)
aOriginal (presenting) fracture
bMajor fracture included—hip, spine, femur, pelvis or humerus
cMinor fracture included—radius, ulna, hand, tibia, fibula, foot, ribs, patella, clavicle, skull, facial
Non-FLS Hospital
Patients aged ≥ 50 years, 
fracture code in ED, 
presenting July-Dec 2010 
N = 1059 
FLS Hospital
Patients aged ≥ 50 years, 
fracture code in ED, 
presenting July-Dec 2010 
N = 807 
Patients included 
N = 416 
Patients included 
N = 515 
Excluded 
N = 643 
Reasons for exclusion 
Duplicates  56 
Not minimal trauma fracture 587 
(No fracture, traumatic injury or both) 
Excluded 
N = 292 
Reasons for exclusion 
Duplicates  22 
Seen in FLS clinic prior to study  12 
Not minimal trauma fracture 258 
(No fracture, traumatic injury or both) 
FLS clinic attendance
N = 515 
Attended clinic 103 
Did not attend clinic 412  
Fig. 1 Flow diagram
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patients without a minimal trauma fracture, and those seen in
FLS clinic prior to the study period were excluded. Five hun-
dred fifteen patients at the FLS hospital and 416 patients at the
non-FLS hospital were included (Fig. 1). The baseline char-
acteristics are shown in Table 1. The FLS hospital recruited a
slightly higher, but not significantly different proportion of
older patients (80. vs 76.2 %). When the original fracture type
was grouped according to three categories (hip, major, minor),
FLS hospital patients had more hip fractures (38.6 vs 22.9 %),
but fewer major, non-hip fractures. When fracture type was
grouped according to two categories (hip/major, minor), FLS
patients were more likely to have a hip/major fracture as their
initial fracture than non-FLS patients (60.8 vs 53.3 %).
During follow-up, FLS hospital patients were less likely to
experience any re-fracture, including both major (8.2 vs
12.0 %) and minor (4.1 vs 4.8 %) re-fractures. In models
adjusting for original fracture site as a two-level variable (ma-
jor vs minor), there was a ∼30 % reduction in the rate of any
re-fracture at the FLS hospital (Table 2). In the final, reduced
model, this effect was significant (sub-distribution hazard ra-
tio (SHR)=0.67, confidence interval (CI) 0.47-0.95, p=
0.025). The cumulative incidence of any re-fracture over the
3-year follow-up period was 16 % in the non-FLS hospital
compared to ∼11 % to the FLS hospital (Fig. 1)
Importantly, the effect was particularly evident in the re-
duction of risk of major re-fractures, with 40 % fewer major
subsequent fractures in the FLS hospital. This effect was sig-
nificant (SHR 0.59, CI 0.39-0.90, p value 0.013) (Table 3).
The cumulative incidence function shows a cumulative inci-
dence of major re-fracture of ∼10.5 % at non-FLS hospital
compared to ∼6 % at FLS hospital during study follow-up
(Fig. 2). The frequency of minor re-fractures at the FLS hos-
pital was lower than the non-FLS hospital (4.1 % compared
with 4.8 %). This reduction was not as marked as that ob-
served for major re-fractures, and as the frequencies of minor
re-fractures at both sites was low, the latter was not analysed as
a separate subgroup (Fig. 3).
To assess whether death rates were significantly higher at
the FLS hospital after accounting for difference in patient
characteristics, we performed an additional analysis. This
was a time-to-event analysis in which the outcome was death
prior to re-fracture. The analysis was performed using Cox
proportional hazard regression. Variables retained in the final
model were BPresenting hospital^, Bage group^, Bgender^ and
Boriginal fracture type^. Factors associated with risk of death
were age ≥65 (hazard ratio (HR)=5.2, p<0.001), male gender
(HR=1.76, p<0.001) and major initial fracture (HR=2.42,
p<0.001). However, after adjusting for these significant pre-
dictors of mortality, there was no significant difference in risk
of death at the FLS vs non-FLS hospital (HR=1.17, p=0.23.
Discussion
We found a significant reduction in risk of any re-fracture of
∼30 % (HR 0.67; CI 0.47-0.95; p 0.025) as well as major re-
fracture of ∼40 %, (HR 0.59; CI 0.39-0.90; p 0.013) in FLS
hospital patients compared to the non-FLS hospital patients.
The cumulative incidence of any re-fracture was ∼16 % at the
non-FLS hospital compared to ∼11 % at FLS hospital during
study follow-up. The cumulative incidence of major re-
fracture was ∼10.5 % at the non-FLS hospital compared to
∼6 % at FLS hospital during study follow-up. Older age and
Table 3 Proportional hazards regression results for major re-fracture:
reduced model (91 major re-fracture events)
Predictor Sub-distribution HR (95 % CI) p value
Presenting hospital:
FLS vs non-FLS hospital 0.59 (0.39, 0.9) 0.013
Age group:
≥65 vs <65 2.50 (1.07, 5.84) 0.035
Gender:
Female vs male 1.83 (1.04, 3.24) 0.037
Original fracture type:
Major vs minor 2.31 (1.33, 4.01) 0.003
Table 2 Proportional hazards regression results for any re-fracture:
final (reduced) model (132 re-fracture events)
Predictor Sub-distribution HR (95 % CI) p value
Presenting hospital:
FLS vs non-FLS hospital 0.67 (0.47, 0.95) 0.025
Age group:
≥65 vs <65 1.79 (1.00, 3.18) 0.049
Original fracture type:
Major vs minor 1.60 (1.05, 2.44) 0.029 Fig. 2 Cumulative incidence of any re-fracture for the FLS and non-FLS
hospitals, adjusted for age group and original fracture type (major/minor)
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having a baseline major fracture placed people at greater risk
of the next fracture.
Importantly, the ∼40 % relative risk reduction in major re-
fractures is in the range of reduction (20-40 %) in non-
vertebral fractures reported from placebo-controlled trials of
the major anti-osteoporosis medications [29]. The magnitude
of the effect of a FLS, however, significantly exceeds the size
of effect reported in clinical trials, which typically include
patients with osteoporosis but without prior fracture. The
number needed to treat (NNT) in these studies is 50–67 to
prevent one hip fracture over 3 years [29] compared to the
NNT of 20 (∼5 % absolute reduction in re-fracture rate over
3 years) seen here. It also compares favourably to such widely
accepted and applied interventions as statin therapy where the
NNT for prevention of one major cardiovascular event in
5 years is 55 [30].
A strength of the study is that it considers the real
life effectiveness of a FLS in reducing re-fracture rates,
by analysing a large number of incident fracture events
in two comparable institutions over defined follow-up
periods. Using a competing risk of death in the analysis
represents the best methods available to validly analyse
observational data. This is one of few studies assessing
the improvement in re-fracture rates due to a FLS. The
majority of previous studies have focused on issues of
implementation and process. While increased investiga-
tions and treatment commencements are reported, dem-
onstration that this then translates into fewer re-fractures
has generally been lacking [18, 22].
Limitations include the retrospective nature of the
study. The reliance of hospital sourced data means that
patients who re-fractured may have presented to another
hospital or health district and may therefore not been
identified. While this risk is likely to have been similar
across the two sites and unlikely to affect the results, if
a bias were to have been present, it is likely to have
operated against the FLS hospital, given the nature of
its referral base whereby all major trauma is channelled
through the one institution, without an adjoining major
population centre that could divert some cases.
While the demographic characteristics of the patient
population of the two hospitals are similar, further risk
factors such as co-morbidities, baseline osteoporotic
treatment, vitamin D status and menopausal history
were not systematically ascertained during the study
and could be possible confounders. Within the limits
of this retrospective observational study, a maximal
number of potential confounders were collected and in-
cluded in statistical analysis. The abovementioned issues
could only be addressed through a randomised con-
trolled trial, clustered by hospital, but would face seri-
ous ethical hurdles given the known risks of osteoporo-
sis and the availability of effective treatment.
The question of which component of a FLS is primarily
responsible for the reduction in re-fracture risk is not ad-
dressed in this report. We and others have previously reported
on the benefit associated with a specialised clinic review [20,
21]. The importance of the current analysis is that it looks at
the overall impact of a FLS and encompasses a range of in-
tangibles such as changes in hospital and general practitioner
culture.
Within those limitations, the findings utilising intention-to-
treat approach of analysing all patients over the age of 50
presenting with a MTF show a significant benefit of a FLS.
Conclusion
There was a ∼30 % reduction in the risk of any re-
fracture and a ∼40 % reduction in major re-fracture in
patients presenting to a hospital with a FLS, when com-
pared to a similar hospital without a FLS. The magni-
tude of effect of a FLS equates to a NNT of 20, to
prevent one re-fracture in 3 years.
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